Hanmi Science To Invest $200 Million To Expand Manufacturing, R&D
By

Hanmi Science, the holding company of Hanmi Pharmaceutical, based in Seoul, Korea, has purchased roughly 200,000 square meters of land in the Yantai Economic and Technological Development Zone in China for about $10 million to construct the group's new production base facilities for the Chinese and global markets.

Hanmi plans to invest $200 million until 2026 in the area to build facilities for the production of chemical and biologic drugs and health supplements, as well as a research and development center for new drug development.

Source: Hanmi Science

Leave a Reply

Your email address will not be published.